Doxorubicin, an anti-cancer drug, is one of the substrates that are transported by P-glycoprotein, which decreases the intracellular drug concentrations by transporting the drugs out of the cells and consequently reduces cytotoxicity21. This evidence concerns the gene ABCB1 and cancer.